Loading...
Mahamaya Lifesciences Ltd. IPO Details – Price, Date, GMP & Analysis
Listed
SME
Price Range:
Rs.114.00
Issue Size:
Rs.70.44 Cr
Lot Size:
1200 shares
Open Date:
November 11
Mahamaya Lifesciences Ltd. IPO Overview
Bidding Dates
November 11 - November 13
Min Investment
₹136,800
Price Range
₹114.00
Issue Size
₹70.44 Cr
IPO DRHP Doc
Company Overview
Mahamaya Lifesciences Limited, established in 2002, specializes in manufacturing and exporting crop protection products and bioproducts. The company focuses on pesticide formulations and supplies to Indian agrochemical firms and MNCs. It also invests in global product registrations, serving markets in various countries.
IPO Timeline
Opens
Nov 11
Closes
Nov 13
Allotment
Nov 14
Refunds
Nov 17
Shares Credit
Nov 17
Listing
Nov 18
Opens
Nov 11
Closes
Nov 13
Allotment
Nov 14
Refunds
Nov 17
Shares Credit
Nov 17
Listing
Nov 18
Latest Subscription Data
| Category | Subscription | Status |
|---|---|---|
| QIB (Qualified Institutional Buyers) | 1.19x | Oversubscribed |
| NII (Non-Institutional Investors/HNI) | 3.63x | Oversubscribed |
| RII (Retail Individual Investors) | 1.02x | Oversubscribed |
| Total Subscription | 1.63x | Oversubscribed |
Last updated: Nov 13, 2025, 06:21 PM
Current GMP:
No Premium
Est. Listing:
Rs.114
Est. Gain:
0%
Star Rating:
★★★★★(0/5)
Financial Information
Financial Data Table
Detailed breakdown of financial metrics across years
| Financial Metric | 2025 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Assets | ₹188.35 Cr | ₹188.35 Cr | ₹112.07 Cr | ₹77.88 Cr |
| EBITDA | ₹24.64 Cr | ₹24.64 Cr | ₹13.36 Cr | ₹8.91 Cr |
| NET Worth | ₹49.42 Cr | ₹49.42 Cr | ₹24.66 Cr | ₹19.44 Cr |
| Profit After Tax | ₹12.94 Cr | ₹12.94 Cr | ₹5.22 Cr | ₹3.75 Cr |
| Reserves and Surplus | ₹31.66 Cr | ₹31.66 Cr | ₹23.41 Cr | ₹18.19 Cr |
| Total Borrowing | ₹58.11 Cr | ₹58.11 Cr | ₹54.63 Cr | ₹24.37 Cr |
| Total Income | ₹267.17 Cr | ₹267.17 Cr | ₹162.83 Cr | ₹137.4 Cr |
Financial data is visualized in the chart above
Strengths & Risks Analysis
Key Risks
Potential challenges and risk factors
- Dependence on third-party distributors for sales and market reach.
- Intense competition in the nutraceutical and herbal segment.
- Regulatory changes in health product approvals may impact operations.
- Limited operating history as a public company under current structure.
- Raw material cost fluctuations may affect profitability.
IPO Details
Mahamaya Lifesciences IPO Details
| Face Value | ₹10 per share |
| Fresh Issue (Ex Market Maker) | 53,29,200 shares (aggregating up to ₹60.75 Cr) |
| IPO Date | November 11, 2025 to November 13, 2025 |
| Issue Price Band | ₹108 to ₹114 per share |
| Issue Price Final | ₹114 per share |
| Issue Type | Bookbuilding IPO |
| Listing At | BSE SME |
| Listing Date | November 18, 2025 |
| Lot Size | 1,200 Shares |
| Net Offered to Public | 58,69,200 shares (aggregating up to ₹66.91 Cr) |
| Offer for Sale | 5,40,000 shares of ₹10 (aggregating up to ₹6.16 Cr) |
| Reserved for Market Maker | 3,09,600 shares (aggregating up to ₹3.53 Cr)Mansi Share & Stock Broking Pvt.Ltd. |
| Sale Type | Fresh Capital-cum-Offer for Sale |
| Share Holding Post Issue | 2,34,05,000 shares |
| Share Holding Pre Issue | 1,77,66,200 shares |
| Total Issue Size | 61,78,800 shares (aggregating up to ₹70.44 Cr) |
Mahamaya Lifesciences IPO Reservation
Share Reservation Distribution
QIB
2,928,000 shares (47.39%)
Retail
2,059,200 shares (33.33%)
Anchor Investors
1,752,000 shares (28.36%)
QIB (Ex-Anchor)
1,176,000 shares (19.03%)
HNI (NII)
882,000 shares (14.27%)
bNII (>₹10L)
588,000 shares (9.52%)
Market Maker
309,600 shares (5.01%)
sNII (<₹10L)
294,000 shares (4.76%)
Mahamaya Lifesciences IPO Promoter Holding
| Promoter Holding Post Issue | 56.35% |
| Promoter Holding Pre Issue | 77.27% |
Mahamaya Lifesciences IPO Listing Details
| BSE Listing Group | MT (Trade to Trade) |
| BSE Script Code | 544611 |
| Final Issue Price | ₹114 per share |
| ISIN | INE0U9D01019 |
| Listing Date | November 18, 2025 |
| NSE Symbol |
Key Dates
Open Date:November 11
Close Date:November 13
Listing Date:November 18
